WallStreetZenWallStreetZen

NASDAQ: ETON
Eton Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ETON

Based on 1 analyst offering 12 month price targets for Eton Pharmaceuticals Inc.
Min Forecast
$10.00+226.8%
Avg Forecast
$10.00+226.8%
Max Forecast
$10.00+226.8%

Should I buy or sell ETON stock?

Based on 1 analyst offering ratings for Eton Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ETON stock forecasts and price targets.

ETON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-11

1 of 1

Forecast return on equity

Is ETON forecast to generate an efficient return?
Company
21.58%
Industry
26.6%
Market
32.84%
ETON's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ETON forecast to generate an efficient return on assets?
Company
10.52%
Industry
11.8%
ETON is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ETON revenue forecast

What is ETON's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$41.4M+26.83%

ETON vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ETON$3.06$10.00+226.80%Buy
TKNO$2.01N/AN/A
ASRT$0.75$3.50+364.19%Strong Buy
DERM$3.58$8.50+137.43%Strong Buy
RGC$5.22N/AN/A
View Top Pharmaceutical Stocks

Eton Pharmaceuticals Stock Forecast FAQ

Is Eton Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ETON) stock is to Buy ETON stock.

Out of 1 analyst, 0 (0%) are recommending ETON as a Strong Buy, 1 (100%) are recommending ETON as a Buy, 0 (0%) are recommending ETON as a Hold, 0 (0%) are recommending ETON as a Sell, and 0 (0%) are recommending ETON as a Strong Sell.

If you're new to stock investing, here's how to buy Eton Pharmaceuticals stock.

What is ETON's revenue growth forecast for 2024-2024?

(NASDAQ: ETON) Eton Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Eton Pharmaceuticals's revenue in 2024 is $32,642,000.

In 2024, ETON is forecast to generate $1,063,485,767 in revenue, with the lowest revenue forecast at $1,063,485,767 and the highest revenue forecast at $1,063,485,767.

What is ETON's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: ETON) forecast ROA is 10.52%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 11.8%.

What is ETON's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ETON price target, the average ETON price target is $10.00, with the highest ETON stock price forecast at $10.00 and the lowest ETON stock price forecast at $10.00.

The Wall Street analyst predicted that Eton Pharmaceuticals's share price could reach $10.00 by Dec 11, 2024. The average Eton Pharmaceuticals stock price prediction forecasts a potential upside of 226.8% from the current ETON share price of $3.06.

What is ETON's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: ETON) forecast ROE is 21.58%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.